LB54640
- Generic Name
- LB54640
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Background
LB54640 is orally-administered small molecule agonist of the melanocortin 4 receptor.
- Associated Conditions
- -
- Associated Therapies
- -
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity
- First Posted Date
- 2023-09-21
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- Rhythm Pharmaceuticals, Inc.
- Target Recruit Count
- 28
- Registration Number
- NCT06046443
- Locations
- 🇰🇷
Seoul National University, Seoul, Gwanak District, Korea, Republic of
🇺🇸Children's Hospital Colorado, Aurora, Colorado, United States
🇺🇸University of Iowa Children's Hospital, Iowa City, Iowa, United States
A Phase 2 Study to Assess Efficacy and Safety of LB54640 in Patients With Genetic Obesity
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-09-18
- Last Posted Date
- 2023-11-02
- Lead Sponsor
- LG Chem
- Target Recruit Count
- 4
- Registration Number
- NCT06041841
- Locations
- 🇫🇷
Pitié Salpêtrière hospital and Sorbonne Université, Paris, France
🇬🇧Cambridge university, Cambridge, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath